Organochalcogen Derivatives in Medicinal Chemistry
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 25 March 2026 | Viewed by 816
Special Issue Editors
Interests: organic synthesis; medicinal chemistry; asymmetric synthesis; organoselenium compounds
Special Issues, Collections and Topics in MDPI journals
Interests: organic synthesis; terpenes; asymmetric synthesis; antioxidants; higher chalcogenides
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Collegues,
An unhealthy lifestyle, pollution and global warming are some of the factors that facilitate the development of diseases like diabetes, hypertension and cancer. Current medicinal chemistry faces the problem of disease prevention and treatment in the context of current environmental issues. Investment in modern protocols and synthetic procedures that fulfill the rules of green chemistry and enable the creation of new bioactive molecules with maximized activity and reduced toxicity must be undertaken. The reactivity of chalcogens (S, Se and Te) has been studied for decades and is still being investigated by research groups worldwide. The application of organochalcogens is broad and covers the field of modern organic synthesis, material science and medicinal chemistry. Their uniqueness is associated with diversified application directions that can be accomplished in accordance with the rules of green chemistry. This Special Issue will focus on innovative synthetic protocols and the applicability of bio-active heterorganic molecules with an incorporated sulfur, selenium or tellurium atom.
Dr. Agata Pacuła-Miszewska
Prof. Dr. Jacek Ścianowski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- organochalcogens
- modern organic synthesis
- medicinal chemistry
- biological activity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
